WAY-261240

Chemical structure of WAY-261240

WAY-261240 is a synthetic compound that acts as a selective estrogen receptor modulator (SERM). It is primarily used in scientific research to study the effects of estrogen receptor activation and modulation in various biological systems.

Chemical Properties

WAY-261240 is characterized by its unique chemical structure, which allows it to selectively bind to estrogen receptors. The compound's molecular formula is C₂₀H₂₁NO₃, and it has a molecular weight of 323.39 g/mol. The structure of WAY-261240 includes a core phenyl ring system with various functional groups that contribute to its binding affinity and selectivity.

Mechanism of Action

WAY-261240 functions by binding to estrogen receptors, which are nuclear hormone receptors that regulate gene expression in response to the hormone estrogen. As a SERM, WAY-261240 can act as an agonist or antagonist depending on the tissue type. This dual action is due to its ability to induce conformational changes in the estrogen receptor, influencing the recruitment of coactivators or corepressors.

Pharmacological Effects

In preclinical studies, WAY-261240 has been shown to exhibit tissue-selective effects. It can mimic the effects of estrogen in certain tissues, such as bone and the cardiovascular system, while blocking estrogenic effects in other tissues, such as the breast and uterus. This makes it a valuable tool for studying the differential effects of estrogen receptor activation.

Research Applications

WAY-261240 is used extensively in research to explore the role of estrogen receptors in various physiological and pathological processes. It is particularly useful in studies investigating the potential therapeutic applications of SERMs in conditions like osteoporosis, breast cancer, and cardiovascular disease.

Safety and Toxicology

As with many research chemicals, the safety profile of WAY-261240 is not fully established. It is primarily used in controlled laboratory settings, and its effects in humans are not well-documented. Researchers handling WAY-261240 must adhere to safety protocols to minimize exposure and potential risks.

Related Pages

• Estrogen receptor
• Selective estrogen receptor modulator
• Osteoporosis
• Breast cancer
• Cardiovascular disease